CLINICAL_TRIALS
trial_result
· 2022-06-27
Clinical Trial Update: Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis [Phase 2]
Summary
Phase 2 trial evaluating RA101495 in generalized myasthenia gravis completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ra Pharmaceuticals | Conditions: Generalized Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2022-06-27